You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple Negative Breast

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Xiaopi granules
  • +2 more
  • (no location specified)
Nov 22, 2023

TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 5, 2023

Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Atezolizumab + RP1
  • Paris, France
    Institut Curie
Oct 2, 2023

Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)

Recruiting
  • Breast Cancer
  • 99mTc-MY6349 SPECT/CT scan
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 24, 2023

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Pembrolizumab injection
    • +2 more
    • (no location specified)
    Jul 25, 2023

    Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Aug 31, 2023

    TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Ga-PSMA PET/CT
    • Brussels, Belgium
      Institut Jules Bordet
    Sep 26, 2023

    Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

    Recruiting
    • Triple Negative Breast Cancer
    • +3 more
    • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 15, 2023

    Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Proleukin 1.3 MG Injection
    • (no location specified)
    Apr 6, 2023

    Breast Tumors Trial in Hangzhou (Sindilimab, Nab-paclitaxel, Lenvatinib)

    Not yet recruiting
    • Breast Neoplasms
    • Hangzhou, Zhejiang, China
      ZhejiangCH
    Nov 17, 2023

    Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University
    May 24, 2023

    Looking At Triple Negative Breast Cancer Patient Experience

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
      • (no location specified)
      Mar 3, 2023

      TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Camrelizumab Plus Chemotherapy and Famitinib
      • Camrelizumab Plus Chemotherapy
      • (no location specified)
      Aug 17, 2023

      TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Alkaline Glucosodiene Molecules
      • (no location specified)
      Jul 14, 2023

      Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

      Not yet recruiting
      • Triple Negative Breast Cancer
      • +2 more
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 25, 2023

      Checkpoint Inhibitors in Triple Negative Breast

      Recruiting
      • Triple Negative Breast Cancer
      • Whole Genome Sequencing
      • +7 more
      • Barcelona, Spain
        Vall d'Hebron Institute of Oncology
      Jun 20, 2023

      Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

      Not yet recruiting
      • Triple-negative Breast Cancer
      • Pembrolizumab 25 mg/ml
      • Paclitaxel injection
      • (no location specified)
      Oct 11, 2023

      Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

      Not yet recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • (no location specified)
      Jun 11, 2023

      Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • (no location specified)
      Oct 5, 2023

      Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

      Not yet recruiting
      • Breast Cancer Triple Negative
      • +3 more
        • Atlanta, Georgia
          Emory University/Winship Cancer Institute
        May 18, 2023

        Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

        Not yet recruiting
        • Triple Negative Breast Cancer
        • Residual Disease
        • (no location specified)
        Nov 15, 2023

        Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

        Not yet recruiting
        • Breast Cancer
        • Contrast Enhanced Ultrasound
        • Hershey, Pennsylvania
          Penn State Health College of Medicine
        Jul 19, 2023

        TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • (no location specified)
        May 8, 2023

        Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

        Not yet recruiting
        • Triple-Negative Breast Cancer
        • Trastuzumab Deruxtecan
        • Shanghai, Shanghai, China
          Breast cancer institute of Fudan University Cancer Hospital
        Jul 12, 2023